Le Lézard
Classified in: Health
Subjects: CCA, FVT

Petros Pharmaceuticals to Participate at Upcoming Benzinga Conference and Interview Show


NEW YORK, Oct. 21, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will participate in the following Benzinga events:

Benzinga All Access Show

Mr. Boctor will participate in Benzinga's All Access Show for a 20-minute interview on Friday, October 22, 2021 at 1:05 PM ET.

During the interview, Mr. Boctor will discuss the latest corporate developments and future growth plans for the company.

Click here to watch:   https://www.youtube.com/watch?v=zTUbSg_HVrQ

Benzinga Global Small Cap Conference

Mr. Boctor will present a corporate overview at the Benzinga Global Small Cap Conference, which is being held virtually on October 27 ? 28, 2021.

Mr. Boctor will deliver his corporate presentation on Wednesday, October 27 at 2:40 PM ET.

Mr. Boctor will be available for one-on-one meetings throughout the conference.

Register for the conference HERE

About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.

SOURCE Petros Pharmaceuticals, Inc.


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: